The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
HY Lin - Chinese Journal of Traumatology, 2020 - mednexus.org
COVID-19 is known for its magical infectivity, fast transmission and high death toll based on
the large number of infected people. From the perspective of the clinical manifestation …
the large number of infected people. From the perspective of the clinical manifestation …
[HTML][HTML] Parallels in sepsis and COVID-19 conditions: implications for managing severe COVID-19
CO Olwal, NN Nganyewo, K Tapela… - Frontiers in …, 2021 - frontiersin.org
Sepsis is a life-threatening systemic illness attributed to a dysregulated host response to
infection. Sepsis is a global burden killing~ 11 million persons annually. In December 2019 …
infection. Sepsis is a global burden killing~ 11 million persons annually. In December 2019 …
Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view
A Kronbichler, M Effenberger, M Eisenhut, KH Lee… - Autoimmunity …, 2020 - Elsevier
Now COVID-19 is causing a severe public health emergency and the mortality is rapidly
increasing all over the world. In the current pandemic era, although there have been many …
increasing all over the world. In the current pandemic era, although there have been many …
Immune-based therapy for COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel zoonotic virus
identified as the cause of coronavirus disease 2019 (COVID-19) that has crossed species …
identified as the cause of coronavirus disease 2019 (COVID-19) that has crossed species …
[PDF][PDF] Adjunct immunotherapies for the management of severely ill COVID-19 patients
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …
[HTML][HTML] CoViD-19 immunopathology and immunotherapy
F Chiappelli, A Khakshooy, G Greenberg - Bioinformation, 2020 - ncbi.nlm.nih.gov
New evidence on the T-cell immuno-pathology in patient's with Corona Virus Disease 2019
(CoViD-19) was reported by Diao et al. in MedRxiv (doi: 10.1101/2020.02. 18.20024364)[1] …
(CoViD-19) was reported by Diao et al. in MedRxiv (doi: 10.1101/2020.02. 18.20024364)[1] …
Advances in immunotherapy for COVID-19: A comprehensive review
M Masoomikarimi, B Garmabi, J Alizadeh… - International …, 2021 - Elsevier
COVID-19 is an acute respiratory syndrome caused by SARS-COV-2 which has now
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
COVID-19 in immunocompromised patients: a systematic review
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first identified as a
novel coronavirus in Wuhan, Hubei province, central China, in December 2019, and is …
novel coronavirus in Wuhan, Hubei province, central China, in December 2019, and is …
[HTML][HTML] Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies
M Zhao - International journal of antimicrobial agents, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2, the causative agent of coronavirus
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
disease 2019 (COVID-19), was declared a pandemic by the World Health Organization on …
[HTML][HTML] Immunomodulation for severe COVID-19 pneumonia: the state of the art
Y Zhang, Y Chen, Z Meng - Frontiers in immunology, 2020 - frontiersin.org
COVID-19 has become a worldwide pandemic caused by the novel coronavirus named
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 …